In plain language
In 230 structural heart procedures at one US center, under-lead pelvic dose to interventional echocardiographers was almost always undetectable. Chest-level dose was higher in mitral and tricuspid cases, and was associated with half-shield-only use and head-of-bed positioning.
At a glance
- Type of study
- Original research, Dosimetry measurement study
- Who was studied
- Other physicians, Mixed lab staff
- Size
- n = 230 procedures
- Where
- United States
- Topics
- Pregnancy and reproductive healthDosimetry and monitoringRoom shielding and protective devicesPersonal protective equipmentWomen in the fieldWorkforce and careersMusculoskeletal injury and ergonomics
- Summary based on
- the full text
What it found
Under-lead pelvic dose was undetectable in nearly all procedures. The modeled fetal dose over a full pregnancy was far below the International Commission on Radiological Protection (ICRP) 1 mSv limit.
Key figures: 0 μSv in 98.7% of cases; ∼2.3 μSv estimated for full pregnancy
Half-shield-only use was independently associated with higher chest-level dose than adjustable full or combination shielding. This was the largest effect in the model.
Key figures: adjusted fold change 3.78; 95% confidence interval (CI): 1.51-9.44; P = 0.005
Chest-level dose to interventional echocardiographers rose from left atrial appendage occlusion (LAAO) to mitral to tricuspid interventions.
Key figures: median 9.0 μSv (IQR: 3.2-21.0) LAAO, 18.0 μSv (7.5-43.5) TMVI, 36.0 μSv (16-116) TTVI; P < 0.001
Head-of-bed positioning was independently associated with about twofold higher chest-level dose. The estimate rests on few cases.
Key figures: adjusted fold change 2.17; 95% CI: 1.06-4.43; P = 0.035, n = 17
Interventional echocardiographers received much higher chest-level doses than sonographers during the same procedures.
Key figures: 10- to 50-fold higher; P < 0.001
Limits to keep in mind
Single-center observational study using one upper-arm dosimeter site, with no eye, thyroid or hand dosimetry, two fluoroscopy systems, few head-of-bed cases (n = 17) and no correction for multiple comparisons. The fetal dose is a modeled estimate from a suprapubic under-lead dosimeter, not a measured fetal dose.
Related research summaries
- SCAI Multi-Society Position Statement on Occupational Health Hazards (2020, Guideline or consensus statement)
- Radiation Realities: Radiation Safety Practices and Awareness Among Interventional Echocardiographers in the United States (2025, Cross-sectional survey)
- Occupational Health Hazards in the Cardiac Catheterization Laboratory: Results of the 2023 SCAI Survey (2025, Cross-sectional survey)
- Radiation Exposure, Training, and Safety in Cardiology (2024, Narrative review)
- Occupational Protection in Interventional Radiology. A Joint Guideline of the Cardiovascular and Interventional Radiological Society of Europe and the Society of Interventional Radiology (2026, Guideline or consensus statement)
How this summary was made
ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.